HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Brd5529

HCID 83288403
New noteNew reactionRequest quotes
Print preview

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1358488-78-4
Standard SMILES
Cc1ccc(C(=O)Nc2cnc(N3CCC(C(N)=O)(N4CCCCC4)CC3)c(C(=O)O)c2)cc1
InChIKey
ZXWHESBABUHJBE-UHFFFAOYSA-N
Molecular formula
C25H31N5O4
Average molar mass
465.5 g/mol
Monoisotopic mass
465.23760449

Names & identifiers

Preferred name
Brd5529
IUPAC
2-(4-carbamoyl-4-piperidin-1-ylpiperidin-1-yl)-5-[(4-methylbenzoyl)amino]pyridine-3-carboxylic acid
English name
BRD5529
Molecular formula
C25H31N5O4
Molecular weight
465.54

Names & synonyms

BRD55292-(4-carbamoyl-4-piperidin-1-ylpiperidin-1-yl)-5-[(4-methylbenzoyl)amino]pyridine-3-carboxylic acid2-(4-carbamoyl-4-piperidin-1-ylpiperidin-1-yl)-5-((4-methylbenzoyl)amino)pyridine-3-carboxylic acidRefChem:4559431358488-78-4methylbenzamido)nicotinic acid2-{4'-carbamoyl-[1,4'-bipiperidin]-1'-yl}-5-(4-methylbenzamido)pyridine-3-carboxylic acid2-(4'-Carbamoyl-[1,4'-bipiperidin]-1'-yl)-5-(4- methylbenzamido)nicotinic acidorb1707514SCHEMBL20870698EX-A9372AKOS021933645
Show more names
BRD5529 (BRD-5529BRD5529 >=98% (HPLC)3-Pyridinecarboxylic acid, 2-[4'-(aminocarbonyl)[1,4'-bipiperidin]-1'-yl]-5-[(4-methylbenzoyl)amino]-
EBC-352042AC-36735DA-61870MS-28578ST110897HY-115497CS-0087206G14315

Database identifiers

CAS
1358488-78-4
PubChem CID
83288403
EC Number
893-540-9

Properties

Computed structural propertiesFilling in

XLogP
-0.1
Topological polar surface area
129 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
7
Rotatable bonds
6
Heavy atoms
34
Formal charge
0
Complexity
740

Physicochemical properties

Boiling point
671.6 · 671.6±55.0 °C(Predicted)
Density
1.327 · 1.327±0.06 g/cm3(Predicted)
storage temp.
2 · 2-8°C
solubility
2 mg/mL, · DMSO: 2mg/mL, clear (warmed)
form
Solid
pka
1.87 · 1.87±0.36(Predicted)
color
Light yellow to yellow
InChIKey
ZXWHESBABUHJBE-UHFFFAOYSA-N
SMILES
CC1=CC=C(C(NC2=CC(C(O)=O)=C(N3CCC(N4CCCCC4)(C(N)=O)CC3)N=C2)=O)C=C1
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
WGK Germany
3 · WGK 3
Storage Class
11 · 11 - Combustible Solids

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Safety data

wgk
WGK 3
Storage Class
11 - Combustible Solids

Chemistry & industry

Applications · 2 items

DescriptionBRD5529 is a selective inhibitor of CARD9, disrupting TRIM62 recruitment. BRD5529 inhibits TRIM62-mediated ubiquitinylation of CARD9, and demonstrates cellular activity and selectivity in CARD9-dependent pathways.

UsesBRD5529 is an effective dose-dependent CARD9-TRIM62 protein–protein interaction (PPI) inhibitor with an IC50 value of 8.6 μM. BRD5529 has potency and complete inhibition of CARD9 ubiquitinylation in vitro, also has favorable solubility. BRD5529 can be used for the research of inflammatory bowel disease (IBD) such as Crohn’s disease (CD) and ulcerative colitis (UC)[1][2].

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes